AKT involvement in cisplatin chemoresistance of human uterine cancer cells
Open Access
- 1 September 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 94 (3) , 785-795
- https://doi.org/10.1016/j.ygyno.2004.06.023
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Role of Ifosfamide in Cervical Cancer: An OverviewOncology, 2003
- Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial PrecancersJNCI Journal of the National Cancer Institute, 2000
- The PI3K‒PDK1 connection: more than just a road to PKBBiochemical Journal, 2000
- Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase ActivityJNCI Journal of the National Cancer Institute, 1999
- Germline PTEN mutations in Cowden syndrome-like families.Journal of Medical Genetics, 1998
- The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-TrisphosphateJournal of Biological Chemistry, 1998
- A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like RegionScience, 1991
- Molecular cloning and characterisation of a novel putative protein‐serine kinase related to the cAMP‐dependent and protein kinase C familiesEuropean Journal of Biochemistry, 1991
- Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily.Proceedings of the National Academy of Sciences, 1991
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983